Key Slides on Reducing HCV in Corrections - Part 1: Surveillance, Screening, Advocacy, and Linkage to Care

This downloadable slideset provides an examination of the burden of HCV in US correctional facilities; guidelines, challenges, and benefits of HCV screening in jails and prisons; the feasibility of HCV treatment in corrections; and strategies for improving linkage to HCV care upon community re-entry.
Matthew J. Akiyama, MD, MSc
Format: Microsoft PowerPoint (.ppt)
File Size: 1.36 MB
Released: October 8, 2019

Acknowledgements

Jointly provided by

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Endorsed by
This activity is supported by independent educational grants from
AbbVie
Gilead Sciences

Related Content

Dr Nancy Reau on exciting viral hepatitis data from EASL 2022, including HBV, HDV (hepatitis delta), and HCV, from Clinical Care Options (CCO)

Nancy Reau, MD Released: July 13, 2022

Clinical Care Options (CCO) expert analysis by Prof Tarik Asselah on new viral hepatitis data from EASL 2022, including HBV, HDV, and HCV

Tarik Asselah, MD, PhD Released: July 8, 2022

Clinical Care Options (CCO) expert analysis by Prof Stefan Zeuzem on new viral hepatitis data from EASL 2022, including HBV, HDV, and HCV

Stefan Zeuzem, MD Released: July 6, 2022

Expert selections of important viral hepatitis data from EASL 2022, including studies of patients with HBV, HDV (hepatitis delta virus), and HCV, from Clinical Care Options (CCO)

Tarik Asselah, MD, PhD Stefan Zeuzem, MD Released: July 6, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings